進行性多巣性白質脳症治療薬の世界市場（～2026年）

• 英文タイトル：Global Progressive Multifocal Leukoencephalopathy Drug Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY14414 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は進行性多巣性白質脳症治療薬のグローバル市場について調査・分析したレポートです。種類別（EBT-103、IKT-01427、メシル酸イマチニブ、NI-307、その他）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別進行性多巣性白質脳症治療薬の競争状況、市場シェア ・世界の進行性多巣性白質脳症治療薬市場：種類別市場規模 2015年-2020年（EBT-103、IKT-01427、メシル酸イマチニブ、NI-307、その他） ・世界の進行性多巣性白質脳症治療薬市場：種類別市場規模予測 2021年-2026年（EBT-103、IKT-01427、メシル酸イマチニブ、NI-307、その他） ・世界の進行性多巣性白質脳症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、研究センター） ・世界の進行性多巣性白質脳症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究センター） ・北米の進行性多巣性白質脳症治療薬市場分析：米国、カナダ ・ヨーロッパの進行性多巣性白質脳症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの進行性多巣性白質脳症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の進行性多巣性白質脳症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの進行性多巣性白質脳症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Excision BioTherapeutics Inc、Humabs BioMed SA、Neurimmune Holding AG、Neuway Pharma GmbH、Pomona Ricerca SRL ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Progressive Multifocal Leukoencephalopathy Drug Market
The global Progressive Multifocal Leukoencephalopathy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Progressive Multifocal Leukoencephalopathy Drug Scope and Market Size
Progressive Multifocal Leukoencephalopathy Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Multifocal Leukoencephalopathy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Progressive Multifocal Leukoencephalopathy Drug market is segmented into
EBT-103
IKT-01427
Imatinib Mesylate
NI-307
Others

Segment by Application, the Progressive Multifocal Leukoencephalopathy Drug market is segmented into
Hospital
Clinic
Research Center

Regional and Country-level Analysis
The Progressive Multifocal Leukoencephalopathy Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Progressive Multifocal Leukoencephalopathy Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Progressive Multifocal Leukoencephalopathy Drug Market Share Analysis
Progressive Multifocal Leukoencephalopathy Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Progressive Multifocal Leukoencephalopathy Drug business, the date to enter into the Progressive Multifocal Leukoencephalopathy Drug market, Progressive Multifocal Leukoencephalopathy Drug product introduction, recent developments, etc.

The major vendors covered:
Excision BioTherapeutics Inc
Humabs BioMed SA
Neurimmune Holding AG
Neuway Pharma GmbH
Pomona Ricerca SRL
…

レポート目次

---

1 Study Coverage
1.1 Progressive Multifocal Leukoencephalopathy Drug Product Introduction
1.2 Market Segments
1.3 Key Progressive Multifocal Leukoencephalopathy Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate by Type
1.4.2 EBT-103
1.4.3 IKT-01427
1.4.4 Imatinib Mesylate
1.4.5 NI-307
1.4.6 Others
1.5 Market by Application
1.5.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Center
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size, Estimates and Forecasts
2.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Revenue 2015-2026
2.1.2 Global Progressive Multifocal Leukoencephalopathy Drug Sales 2015-2026
2.2 Global Progressive Multifocal Leukoencephalopathy Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Progressive Multifocal Leukoencephalopathy Drug Competitor Landscape by Players
3.1 Progressive Multifocal Leukoencephalopathy Drug Sales by Manufacturers
3.1.1 Progressive Multifocal Leukoencephalopathy Drug Sales by Manufacturers (2015-2020)
3.1.2 Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Progressive Multifocal Leukoencephalopathy Drug Revenue by Manufacturers
3.2.1 Progressive Multifocal Leukoencephalopathy Drug Revenue by Manufacturers (2015-2020)
3.2.2 Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Progressive Multifocal Leukoencephalopathy Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Progressive Multifocal Leukoencephalopathy Drug Revenue in 2019
3.2.5 Global Progressive Multifocal Leukoencephalopathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Progressive Multifocal Leukoencephalopathy Drug Price by Manufacturers
3.4 Progressive Multifocal Leukoencephalopathy Drug Manufacturing Base Distribution, Product Types
3.4.1 Progressive Multifocal Leukoencephalopathy Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Progressive Multifocal Leukoencephalopathy Drug Product Type
3.4.3 Date of International Manufacturers Enter into Progressive Multifocal Leukoencephalopathy Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size by Type (2015-2020)
4.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020)
4.1.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Type (2015-2020)
4.1.3 Progressive Multifocal Leukoencephalopathy Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Type (2021-2026)
4.2.3 Progressive Multifocal Leukoencephalopathy Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Progressive Multifocal Leukoencephalopathy Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size by Application (2015-2020)
5.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020)
5.1.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Application (2015-2020)
5.1.3 Progressive Multifocal Leukoencephalopathy Drug Price by Application (2015-2020)
5.2 Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Progressive Multifocal Leukoencephalopathy Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Progressive Multifocal Leukoencephalopathy Drug by Country
6.1.1 North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country
6.1.2 North America Progressive Multifocal Leukoencephalopathy Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Type
6.3 North America Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Progressive Multifocal Leukoencephalopathy Drug by Country
7.1.1 Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country
7.1.2 Europe Progressive Multifocal Leukoencephalopathy Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Type
7.3 Europe Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug by Region
8.1.1 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Region
8.1.2 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Type
8.3 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Progressive Multifocal Leukoencephalopathy Drug by Country
9.1.1 Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Country
9.1.2 Latin America Progressive Multifocal Leukoencephalopathy Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Type
9.3 Central & South America Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug by Country
10.1.1 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country
10.1.2 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Type
10.3 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Excision BioTherapeutics Inc
11.1.1 Excision BioTherapeutics Inc Corporation Information
11.1.2 Excision BioTherapeutics Inc Description and Business Overview
11.1.3 Excision BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.1.5 Excision BioTherapeutics Inc Related Developments
11.2 Humabs BioMed SA
11.2.1 Humabs BioMed SA Corporation Information
11.2.2 Humabs BioMed SA Description and Business Overview
11.2.3 Humabs BioMed SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.2.5 Humabs BioMed SA Related Developments
11.3 Neurimmune Holding AG
11.3.1 Neurimmune Holding AG Corporation Information
11.3.2 Neurimmune Holding AG Description and Business Overview
11.3.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.3.5 Neurimmune Holding AG Related Developments
11.4 Neuway Pharma GmbH
11.4.1 Neuway Pharma GmbH Corporation Information
11.4.2 Neuway Pharma GmbH Description and Business Overview
11.4.3 Neuway Pharma GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.4.5 Neuway Pharma GmbH Related Developments
11.5 Pomona Ricerca SRL
11.5.1 Pomona Ricerca SRL Corporation Information
11.5.2 Pomona Ricerca SRL Description and Business Overview
11.5.3 Pomona Ricerca SRL Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.5.5 Pomona Ricerca SRL Related Developments
11.1 Excision BioTherapeutics Inc
11.1.1 Excision BioTherapeutics Inc Corporation Information
11.1.2 Excision BioTherapeutics Inc Description and Business Overview
11.1.3 Excision BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Products Offered
11.1.5 Excision BioTherapeutics Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Progressive Multifocal Leukoencephalopathy Drug Market Estimates and Projections by Region
12.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Regions 2021-2026
12.2 North America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast (2021-2026)
12.2.1 North America: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast (2021-2026)
12.2.2 North America: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast (2021-2026)
12.2.3 North America: Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast (2021-2026)
12.3.2 Europe: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Progressive Multifocal Leukoencephalopathy Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Progressive Multifocal Leukoencephalopathy Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Progressive Multifocal Leukoencephalopathy Drug Market Segments
Table 2. Ranking of Global Top Progressive Multifocal Leukoencephalopathy Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of EBT-103
Table 5. Major Manufacturers of IKT-01427
Table 6. Major Manufacturers of Imatinib Mesylate
Table 7. Major Manufacturers of NI-307
Table 8. Major Manufacturers of Others
Table 9. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Progressive Multifocal Leukoencephalopathy Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Progressive Multifocal Leukoencephalopathy Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Progressive Multifocal Leukoencephalopathy Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Progressive Multifocal Leukoencephalopathy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Multifocal Leukoencephalopathy Drug as of 2019)
Table 18. Progressive Multifocal Leukoencephalopathy Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Progressive Multifocal Leukoencephalopathy Drug Price (2015-2020) (USD/Pcs)
Table 21. Progressive Multifocal Leukoencephalopathy Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Progressive Multifocal Leukoencephalopathy Drug Product Type
Table 23. Date of International Manufacturers Enter into Progressive Multifocal Leukoencephalopathy Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Progressive Multifocal Leukoencephalopathy Drug Sales Share by Type (2015-2020)
Table 27. Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Type (2015-2020)
Table 29. Progressive Multifocal Leukoencephalopathy Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Progressive Multifocal Leukoencephalopathy Drug Sales Share by Application (2015-2020)
Table 32. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2015-2020)
Table 34. North America Progressive Multifocal Leukoencephalopathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Table 38. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Progressive Multifocal Leukoencephalopathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Progressive Multifocal Leukoencephalopathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Table 72. Excision BioTherapeutics Inc Corporation Information
Table 73. Excision BioTherapeutics Inc Description and Major Businesses
Table 74. Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Excision BioTherapeutics Inc Product
Table 76. Excision BioTherapeutics Inc Recent Development
Table 77. Humabs BioMed SA Corporation Information
Table 78. Humabs BioMed SA Description and Major Businesses
Table 79. Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Humabs BioMed SA Product
Table 81. Humabs BioMed SA Recent Development
Table 82. Neurimmune Holding AG Corporation Information
Table 83. Neurimmune Holding AG Description and Major Businesses
Table 84. Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Neurimmune Holding AG Product
Table 86. Neurimmune Holding AG Recent Development
Table 87. Neuway Pharma GmbH Corporation Information
Table 88. Neuway Pharma GmbH Description and Major Businesses
Table 89. Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Neuway Pharma GmbH Product
Table 91. Neuway Pharma GmbH Recent Development
Table 92. Pomona Ricerca SRL Corporation Information
Table 93. Pomona Ricerca SRL Description and Major Businesses
Table 94. Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Pomona Ricerca SRL Product
Table 96. Pomona Ricerca SRL Recent Development
Table 97. Global Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Progressive Multifocal Leukoencephalopathy Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Progressive Multifocal Leukoencephalopathy Drug Players
Table 115. Progressive Multifocal Leukoencephalopathy Drug Customers List
Table 116. Progressive Multifocal Leukoencephalopathy Drug Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Progressive Multifocal Leukoencephalopathy Drug Product Picture
Figure 2. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type in 2020 & 2026
Figure 3. EBT-103 Product Picture
Figure 4. IKT-01427 Product Picture
Figure 5. Imatinib Mesylate Product Picture
Figure 6. NI-307 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Research Center
Figure 12. Progressive Multifocal Leukoencephalopathy Drug Report Years Considered
Figure 13. Global Progressive Multifocal Leukoencephalopathy Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Progressive Multifocal Leukoencephalopathy Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Region in 2019
Figure 18. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region in 2019
Figure 20. Global Progressive Multifocal Leukoencephalopathy Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Progressive Multifocal Leukoencephalopathy Drug Revenue in 2019
Figure 22. Progressive Multifocal Leukoencephalopathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Type in 2019
Figure 25. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Type in 2019
Figure 27. Global Progressive Multifocal Leukoencephalopathy Drug Market Share by Price Range (2015-2020)
Figure 28. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Application in 2019
Figure 30. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Application in 2019
Figure 32. North America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country in 2019
Figure 35. North America Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Progressive Multifocal Leukoencephalopathy Drug Market Share by Type in 2019
Figure 41. North America Progressive Multifocal Leukoencephalopathy Drug Market Share by Application in 2019
Figure 42. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country in 2019
Figure 45. Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country in 2019
Figure 46. Germany Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Progressive Multifocal Leukoencephalopathy Drug Market Share by Type in 2019
Figure 57. Europe Progressive Multifocal Leukoencephalopathy Drug Market Share by Application in 2019
Figure 58. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Region in 2019
Figure 62. China Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Market Share by Type in 2019
Figure 85. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Market Share by Application in 2019
Figure 86. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country in 2019
Figure 89. Latin America Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Share by Type in 2019
Figure 97. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Share by Application in 2019
Figure 110. North America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---